[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fa-78R0iehQ9Mj335ch3-TXCi7QchE_TBhfmXQnd2d0I":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":34,"phaseBuckets":45,"rows":52},"Harvard School of Public Health (HSPH)",[4],153,false,19,20,2493770,5,141,[14,17,20,23,25,28,30,32],{"name":15,"count":16},"HIV Infections",12,{"name":18,"count":19},"Anemia",11,{"name":21,"count":22},"HIV Infection",8,{"name":24,"count":22},"Obesity",{"name":26,"count":27},"Cardiovascular Diseases",6,{"name":29,"count":27},"Tobacco Use Cessation",{"name":31,"count":11},"Health Behavior",{"name":33,"count":11},"Heart Diseases",[35,40],{"nctId":36,"briefTitle":37,"date":38,"intervention":39},"NCT02369406","Early Infant HIV Treatment in Botswana","2020-11-06","Nevirapine",{"nctId":41,"briefTitle":42,"date":43,"intervention":44},"NCT05393193","POC HIV Testing and Early DTG Use for Infants","2026-05-31","DTG\u002FABC\u002F3TC",[46,47,48,49,50,51],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[53,78,103,121,139,170,197,222,252,270,288,306,324,342,370,388,414,432,459,484,502,526],{"intervention":44,"totalTrials":54,"cells":55},1,{"EARLY_PHASE1":56,"PHASE1":59,"PHASE2":61,"PHASE3":63,"PHASE4":65,"NA":76},{"trials":57,"activeCount":58},[],0,{"trials":60,"activeCount":58},[],{"trials":62,"activeCount":58},[],{"trials":64,"activeCount":58},[],{"trials":66,"activeCount":54,"soonestReadout":43},[67],{"nctId":41,"briefTitle":42,"status":68,"phases":69,"primaryCompletion":43,"completion":70,"start":71,"enrollment":72,"conditions":73,"interventions":75},"ACTIVE_NOT_RECRUITING",[50],"2026-08-31","2022-07-04",900,[74],"HIV",[44],{"trials":77,"activeCount":58},[],{"intervention":79,"totalTrials":54,"cells":80},"Kaletra",{"EARLY_PHASE1":81,"PHASE1":83,"PHASE2":85,"PHASE3":87,"PHASE4":99,"NA":101},{"trials":82,"activeCount":58},[],{"trials":84,"activeCount":58},[],{"trials":86,"activeCount":58},[],{"trials":88,"activeCount":54,"soonestReadout":38},[89],{"nctId":36,"briefTitle":37,"status":68,"phases":90,"primaryCompletion":38,"completion":91,"start":92,"enrollment":93,"conditions":94,"interventions":96},[48,49],"2029-06-30","2015-05-04",67,[74,95],"Pediatric AIDS",[39,79,97,98],"Lamivudine","Zidovudine",{"trials":100,"activeCount":58},[],{"trials":102,"activeCount":58},[],{"intervention":97,"totalTrials":54,"cells":104},{"EARLY_PHASE1":105,"PHASE1":107,"PHASE2":109,"PHASE3":111,"PHASE4":117,"NA":119},{"trials":106,"activeCount":58},[],{"trials":108,"activeCount":58},[],{"trials":110,"activeCount":58},[],{"trials":112,"activeCount":54,"soonestReadout":38},[113],{"nctId":36,"briefTitle":37,"status":68,"phases":114,"primaryCompletion":38,"completion":91,"start":92,"enrollment":93,"conditions":115,"interventions":116},[48,49],[74,95],[39,79,97,98],{"trials":118,"activeCount":58},[],{"trials":120,"activeCount":58},[],{"intervention":98,"totalTrials":54,"cells":122},{"EARLY_PHASE1":123,"PHASE1":125,"PHASE2":127,"PHASE3":129,"PHASE4":135,"NA":137},{"trials":124,"activeCount":58},[],{"trials":126,"activeCount":58},[],{"trials":128,"activeCount":58},[],{"trials":130,"activeCount":54,"soonestReadout":38},[131],{"nctId":36,"briefTitle":37,"status":68,"phases":132,"primaryCompletion":38,"completion":91,"start":92,"enrollment":93,"conditions":133,"interventions":134},[48,49],[74,95],[39,79,97,98],{"trials":136,"activeCount":58},[],{"trials":138,"activeCount":58},[],{"intervention":39,"totalTrials":140,"cells":141},2,{"EARLY_PHASE1":142,"PHASE1":144,"PHASE2":146,"PHASE3":148,"PHASE4":154,"NA":156},{"trials":143,"activeCount":58},[],{"trials":145,"activeCount":58},[],{"trials":147,"activeCount":58},[],{"trials":149,"activeCount":54,"soonestReadout":38},[150],{"nctId":36,"briefTitle":37,"status":68,"phases":151,"primaryCompletion":38,"completion":91,"start":92,"enrollment":93,"conditions":152,"interventions":153},[48,49],[74,95],[39,79,97,98],{"trials":155,"activeCount":58},[],{"trials":157,"activeCount":58},[158],{"nctId":159,"briefTitle":160,"status":161,"phases":162,"primaryCompletion":163,"start":164,"enrollment":165,"conditions":166,"interventions":168},"NCT00197587","Prevention of Milk-Borne Transmission of HIV-1C in Botswana","COMPLETED",[51],"2005-05","2002-08",1200,[21,167],"Infant Risk for HIV Infection by MTCT",[39,169],"No intervention",{"intervention":171,"totalTrials":54,"cells":172},"cotrimoxazole",{"EARLY_PHASE1":173,"PHASE1":175,"PHASE2":177,"PHASE3":179,"PHASE4":181,"NA":195},{"trials":174,"activeCount":58},[],{"trials":176,"activeCount":58},[],{"trials":178,"activeCount":58},[],{"trials":180,"activeCount":58},[],{"trials":182,"activeCount":58},[183],{"nctId":184,"briefTitle":185,"status":161,"phases":186,"primaryCompletion":187,"completion":187,"start":188,"enrollment":189,"conditions":190,"interventions":194},"NCT01086878","Safety of Cotrimoxazole in HIV- and HAART-exposed Infants",[50],"2010-10","2009-02",222,[191,192,18,193,15],"Acquired Immunodeficiency Syndrome","Infant, Newborn","Neutropenia",[171],{"trials":196,"activeCount":58},[],{"intervention":198,"totalTrials":54,"cells":199},"Multivitamins - vitamins B complex, C and E",{"EARLY_PHASE1":200,"PHASE1":202,"PHASE2":204,"PHASE3":206,"PHASE4":218,"NA":220},{"trials":201,"activeCount":58},[],{"trials":203,"activeCount":58},[],{"trials":205,"activeCount":58},[],{"trials":207,"activeCount":58},[208],{"nctId":209,"briefTitle":210,"status":161,"phases":211,"primaryCompletion":212,"completion":212,"start":213,"enrollment":214,"conditions":215,"interventions":217},"NCT00197730","Trial of Vitamins Among Children of HIV-infected Women",[49],"2008-05","2004-06",2387,[15,216],"Pregnancy Complications",[198],{"trials":219,"activeCount":58},[],{"trials":221,"activeCount":58},[],{"intervention":223,"totalTrials":54,"cells":224},"(A) zidovudine, lamivudine and nevirapine",{"EARLY_PHASE1":225,"PHASE1":227,"PHASE2":229,"PHASE3":231,"PHASE4":248,"NA":250},{"trials":226,"activeCount":58},[],{"trials":228,"activeCount":58},[],{"trials":230,"activeCount":58},[],{"trials":232,"activeCount":58},[233],{"nctId":234,"briefTitle":235,"status":161,"phases":236,"completion":237,"start":238,"enrollment":239,"conditions":240,"interventions":242},"NCT00197613","The Adult Antiretroviral Treatment and Resistance Study (Tshepo)",[49],"2007-12","2002-12",650,[241,21],"AIDS",[223,243,244,245,246,247],"(B) zidovudine, lamivudine and efavirenz","(C) zidovudine, didanosine, and nevirapine","(D) zidovudine, didanosine, and efavirenz","(E) stavudine, lamivudine, and nevirapine","(F) stavudine, lamivudine and efavirenz",{"trials":249,"activeCount":58},[],{"trials":251,"activeCount":58},[],{"intervention":243,"totalTrials":54,"cells":253},{"EARLY_PHASE1":254,"PHASE1":256,"PHASE2":258,"PHASE3":260,"PHASE4":266,"NA":268},{"trials":255,"activeCount":58},[],{"trials":257,"activeCount":58},[],{"trials":259,"activeCount":58},[],{"trials":261,"activeCount":58},[262],{"nctId":234,"briefTitle":235,"status":161,"phases":263,"completion":237,"start":238,"enrollment":239,"conditions":264,"interventions":265},[49],[241,21],[223,243,244,245,246,247],{"trials":267,"activeCount":58},[],{"trials":269,"activeCount":58},[],{"intervention":244,"totalTrials":54,"cells":271},{"EARLY_PHASE1":272,"PHASE1":274,"PHASE2":276,"PHASE3":278,"PHASE4":284,"NA":286},{"trials":273,"activeCount":58},[],{"trials":275,"activeCount":58},[],{"trials":277,"activeCount":58},[],{"trials":279,"activeCount":58},[280],{"nctId":234,"briefTitle":235,"status":161,"phases":281,"completion":237,"start":238,"enrollment":239,"conditions":282,"interventions":283},[49],[241,21],[223,243,244,245,246,247],{"trials":285,"activeCount":58},[],{"trials":287,"activeCount":58},[],{"intervention":245,"totalTrials":54,"cells":289},{"EARLY_PHASE1":290,"PHASE1":292,"PHASE2":294,"PHASE3":296,"PHASE4":302,"NA":304},{"trials":291,"activeCount":58},[],{"trials":293,"activeCount":58},[],{"trials":295,"activeCount":58},[],{"trials":297,"activeCount":58},[298],{"nctId":234,"briefTitle":235,"status":161,"phases":299,"completion":237,"start":238,"enrollment":239,"conditions":300,"interventions":301},[49],[241,21],[223,243,244,245,246,247],{"trials":303,"activeCount":58},[],{"trials":305,"activeCount":58},[],{"intervention":246,"totalTrials":54,"cells":307},{"EARLY_PHASE1":308,"PHASE1":310,"PHASE2":312,"PHASE3":314,"PHASE4":320,"NA":322},{"trials":309,"activeCount":58},[],{"trials":311,"activeCount":58},[],{"trials":313,"activeCount":58},[],{"trials":315,"activeCount":58},[316],{"nctId":234,"briefTitle":235,"status":161,"phases":317,"completion":237,"start":238,"enrollment":239,"conditions":318,"interventions":319},[49],[241,21],[223,243,244,245,246,247],{"trials":321,"activeCount":58},[],{"trials":323,"activeCount":58},[],{"intervention":247,"totalTrials":54,"cells":325},{"EARLY_PHASE1":326,"PHASE1":328,"PHASE2":330,"PHASE3":332,"PHASE4":338,"NA":340},{"trials":327,"activeCount":58},[],{"trials":329,"activeCount":58},[],{"trials":331,"activeCount":58},[],{"trials":333,"activeCount":58},[334],{"nctId":234,"briefTitle":235,"status":161,"phases":335,"completion":237,"start":238,"enrollment":239,"conditions":336,"interventions":337},[49],[241,21],[223,243,244,245,246,247],{"trials":339,"activeCount":58},[],{"trials":341,"activeCount":58},[],{"intervention":343,"totalTrials":54,"cells":344},"Zinc",{"EARLY_PHASE1":345,"PHASE1":347,"PHASE2":349,"PHASE3":351,"PHASE4":366,"NA":368},{"trials":346,"activeCount":58},[],{"trials":348,"activeCount":58},[],{"trials":350,"activeCount":58},[],{"trials":352,"activeCount":58},[353],{"nctId":354,"briefTitle":355,"status":161,"phases":356,"primaryCompletion":357,"completion":357,"start":358,"enrollment":359,"conditions":360,"interventions":364},"NCT00421668","A Trial of Zinc and Micronutrients in Tanzanian Children",[49],"2012-10","2007-09",2400,[361,362,363],"Diarrheal Illnesses","Respiratory Illness","Growth Faltering",[343,365],"Multivitamins",{"trials":367,"activeCount":58},[],{"trials":369,"activeCount":58},[],{"intervention":365,"totalTrials":54,"cells":371},{"EARLY_PHASE1":372,"PHASE1":374,"PHASE2":376,"PHASE3":378,"PHASE4":384,"NA":386},{"trials":373,"activeCount":58},[],{"trials":375,"activeCount":58},[],{"trials":377,"activeCount":58},[],{"trials":379,"activeCount":58},[380],{"nctId":354,"briefTitle":355,"status":161,"phases":381,"primaryCompletion":357,"completion":357,"start":358,"enrollment":359,"conditions":382,"interventions":383},[49],[361,362,363],[343,365],{"trials":385,"activeCount":58},[],{"trials":387,"activeCount":58},[],{"intervention":389,"totalTrials":54,"cells":390},"cotrimoxazole prophylaxis",{"EARLY_PHASE1":391,"PHASE1":393,"PHASE2":395,"PHASE3":408,"PHASE4":410,"NA":412},{"trials":392,"activeCount":58},[],{"trials":394,"activeCount":58},[],{"trials":396,"activeCount":58},[397],{"nctId":398,"briefTitle":399,"status":161,"phases":400,"primaryCompletion":401,"completion":402,"start":403,"enrollment":404,"conditions":405,"interventions":406},"NCT01229761","Study to Improve Survival Among HIV-Exposed Infants in Botswana",[48],"2015-03","2018-10","2011-05",3724,[15,193,18],[389,407],"cotrimoxazole placebo",{"trials":409,"activeCount":58},[],{"trials":411,"activeCount":58},[],{"trials":413,"activeCount":58},[],{"intervention":407,"totalTrials":54,"cells":415},{"EARLY_PHASE1":416,"PHASE1":418,"PHASE2":420,"PHASE3":426,"PHASE4":428,"NA":430},{"trials":417,"activeCount":58},[],{"trials":419,"activeCount":58},[],{"trials":421,"activeCount":58},[422],{"nctId":398,"briefTitle":399,"status":161,"phases":423,"primaryCompletion":401,"completion":402,"start":403,"enrollment":404,"conditions":424,"interventions":425},[48],[15,193,18],[389,407],{"trials":427,"activeCount":58},[],{"trials":429,"activeCount":58},[],{"trials":431,"activeCount":58},[],{"intervention":433,"totalTrials":54,"cells":434},"methyl donor",{"EARLY_PHASE1":435,"PHASE1":437,"PHASE2":451,"PHASE3":453,"PHASE4":455,"NA":457},{"trials":436,"activeCount":58},[],{"trials":438,"activeCount":58},[439],{"nctId":440,"briefTitle":441,"status":161,"phases":442,"primaryCompletion":443,"completion":443,"start":444,"enrollment":445,"conditions":446,"interventions":450},"NCT01864824","Air Pollution, Epigenetics and Cardiovascular Health: A Human Intervention Trial",[47],"2014-07","2013-06",10,[447,448,449],"Heart Rate","Heart Rate Variability","Inflammation",[433],{"trials":452,"activeCount":58},[],{"trials":454,"activeCount":58},[],{"trials":456,"activeCount":58},[],{"trials":458,"activeCount":58},[],{"intervention":460,"totalTrials":54,"cells":461},"intranasal oxytocin",{"EARLY_PHASE1":462,"PHASE1":464,"PHASE2":466,"PHASE3":468,"PHASE4":470,"NA":472},{"trials":463,"activeCount":58},[],{"trials":465,"activeCount":58},[],{"trials":467,"activeCount":58},[],{"trials":469,"activeCount":58},[],{"trials":471,"activeCount":58},[],{"trials":473,"activeCount":58},[474],{"nctId":475,"briefTitle":476,"status":161,"phases":477,"primaryCompletion":478,"completion":478,"start":188,"enrollment":479,"conditions":480,"interventions":483},"NCT01011465","The Biology of Resilience",[51],"2012-04",270,[481,482],"Oxytocin","Placebo",[460],{"intervention":169,"totalTrials":54,"cells":485},{"EARLY_PHASE1":486,"PHASE1":488,"PHASE2":490,"PHASE3":492,"PHASE4":494,"NA":496},{"trials":487,"activeCount":58},[],{"trials":489,"activeCount":58},[],{"trials":491,"activeCount":58},[],{"trials":493,"activeCount":58},[],{"trials":495,"activeCount":58},[],{"trials":497,"activeCount":58},[498],{"nctId":159,"briefTitle":160,"status":161,"phases":499,"primaryCompletion":163,"start":164,"enrollment":165,"conditions":500,"interventions":501},[51],[21,167],[39,169],{"intervention":503,"totalTrials":54,"cells":504},"Ritonavir-boosted indinavir",{"EARLY_PHASE1":505,"PHASE1":507,"PHASE2":509,"PHASE3":511,"PHASE4":513,"NA":515},{"trials":506,"activeCount":58},[],{"trials":508,"activeCount":58},[],{"trials":510,"activeCount":58},[],{"trials":512,"activeCount":58},[],{"trials":514,"activeCount":58},[],{"trials":516,"activeCount":58},[517],{"nctId":518,"briefTitle":519,"status":161,"phases":520,"primaryCompletion":521,"completion":522,"start":523,"enrollment":8,"conditions":524,"interventions":525},"NCT00197639","Pharmacokinetic Study of Indinavir Drug Levels When Boosted With Ritonavir in Thailand",[],"2009-05","2010-08","2006-09",[21],[503],{"intervention":527,"totalTrials":54,"cells":528},"highly active antiretroviral therapy: Lopinavir\u002FRitonavir, Lamivudine, Zidovudine, Efavirenz, Tenofovir Disoproxil Fumarate, Emtricitabine",{"EARLY_PHASE1":529,"PHASE1":531,"PHASE2":533,"PHASE3":535,"PHASE4":537,"NA":539},{"trials":530,"activeCount":58},[],{"trials":532,"activeCount":58},[],{"trials":534,"activeCount":58},[],{"trials":536,"activeCount":58},[],{"trials":538,"activeCount":58},[],{"trials":540,"activeCount":58},[541],{"nctId":542,"briefTitle":543,"status":544,"phases":545,"primaryCompletion":546,"completion":547,"start":548,"enrollment":19,"conditions":549,"interventions":550},"NCT01583439","The Mochudi Prevention Project ART Protocol","TERMINATED",[51],"2013-02","2013-09","2012-09",[15],[527]]